A comparison of seven methods to analyze heparin in biomaterials: quantification, location, and anticoagulant activity.

Glycosaminoglycans, like heparin, are frequently incorporated in biomaterials because of their capacity to bind and store growth factors and because of their hydrating properties. Heparin is also often used in biomaterials for its anticoagulant activity. Analysis of biomaterial-bound heparin is challenging because most assays are based on heparin in solution. In this study, seven different methods were probed to analyze heparin covalently attached to collagen scaffolds. For each method, the basic mechanism and the advantages and disadvantages are given. An analysis by the factor Xa assay and the Farndale assay clearly indicated that the amount of immobilized heparin cannot be determined correctly when the scaffold is intact. Scaffolds had to be proteolytically digested or acid treated to obtain reliable measurements. Methods used to quantify the amount of bound heparin included a hexosamine assay, an uronic acid assay, a Farndale assay, agarose gel electrophoresis, and immuno-dot blot analysis. Location and semiquantification of heparin were accomplished by immunofluorescence. Although all assays had their advantages and disadvantages, the hexosamine assay turned out to be the most robust and is recommended as the preferred assay to quantify the amount of heparin bound to scaffolds. It is applicable to all scaffolds that are acid hydrolyzable. This study may allow researchers in the field to select the most appropriate method to analyze glycosaminoglycans in biomaterials.

[1]  D. Bezuidenhout,et al.  Covalent Surface Heparinization Potentiates Porous Polyurethane Scaffold Vascularization , 2010, Journal of biomaterials applications.

[2]  L. P. Van den Heuvel,et al.  Characterization of anticoagulant heparinoids by immunoprofiling , 2007, Glycoconjugate Journal.

[3]  T. V. van Kuppevelt,et al.  Construction of collagen scaffolds that mimic the three-dimensional architecture of specific tissues. , 2007, Tissue engineering.

[4]  E. Chaikof,et al.  Novel thromboresistant materials. , 2007, Journal of vascular surgery.

[5]  J. Schalkwijk,et al.  Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. , 2007, Biomaterials.

[6]  S. Olson,et al.  Heparin Enhances the Specificity of Antithrombin for Thrombin and Factor Xa Independent of the Reactive Center Loop Sequence , 2001, The Journal of Biological Chemistry.

[7]  J. Feijen,et al.  Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. , 2001, Biomaterials.

[8]  J. Veerkamp,et al.  Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. , 2000, Biomaterials.

[9]  A Oosterhof,et al.  Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. , 1999, Biomaterials.

[10]  R. Hoet,et al.  Generation and Application of Type-specific Anti-Heparan Sulfate Antibodies Using Phage Display Technology , 1998, The Journal of Biological Chemistry.

[11]  P. R. van Weeren,et al.  A microtiter plate assay for the determination of uronic acids. , 1998, Analytical biochemistry.

[12]  E. Versteeg,et al.  A spectrometric method for the determination of heparan sulfate , 1994 .

[13]  E. Versteeg,et al.  Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels. , 1994, Analytical biochemistry.

[14]  S. W. Kim,et al.  Macromolecular release from collagen monolithic devices. , 1990, Journal of biomedical materials research.

[15]  I. Björk,et al.  Mechanism of the anticoagulant action of heparin , 1982, Molecular and Cellular Biochemistry.

[16]  I. Yannas,et al.  Design of an artificial skin. II. Control of chemical composition. , 1980, Journal of biomedical materials research.

[17]  B. Casu,et al.  Studies on the Conformation of Heparin by 1H and 13C NMR Spectroscopy , 1979 .

[18]  M. Lie,et al.  Assay of heparin in plasma using a chromogenic substrate for activated factor X. , 1976, Thrombosis research.

[19]  P. Buma,et al.  From molecules to matrix: construction and evaluation of molecularly defined bioscaffolds. , 2006, Advances in experimental medicine and biology.

[20]  P. Jemth,et al.  Nitrocellulose filter binding to assess binding of glycosaminoglycans to proteins. , 2003, Methods in enzymology.

[21]  J. Feijen,et al.  Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. , 1996, Biomaterials.

[22]  R W Farndale,et al.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. , 1982, Connective tissue research.

[23]  L. A. Elson,et al.  A colorimetric method for the determination of glucosamine and chondrosamine. , 1933, The Biochemical journal.